• Maya Bolger-Chen & Ruei-Jen Abraham-Fan

    MR5 Room 3005
    CVRC Seminar Series

    Cavitation-facilitated AAV Gene Therapy for Cardiovascular and Muscular Disorders (Maya) Druggable Pathways Involving Platelet Signaling for Slowing Aortic Stenosis Progression (Ruie-Jen) In the first half of the series, we will review progress to date on augmenting AAV gene therapy by … Read More

  • Monica Santisteban, PhD

    MR5 Room 3005
    CVRC Seminar Series

    Contributions of hypertension to cognitive decline and Alzheimer’s disease  Assistant Professor of Medicine Assistant Professor of Medicine, Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine Vanderbilt University Medical Center, Nashville, TN

  • Elisa Boscolo, PhD

    MR5 Room 3005
    CVRC Seminar Series

    Cellular and molecular mechanisms driving aberrant development in a novel model of Venous Malformation  Patients with venous malformation (VM) develop vascular lesions consisting of massively enlarged and dysmorphic veins. These lesions cause significant disfigurement, chronic pain, and complications such as bleeding and … Read More

  • Nick Leeper, M.D.

    MR5 Room 3005
    CVRC Seminar Series

    TBD Professor of Medicine & Surgery, Director of Vascular Research, and Chief of Vascular Medicine, Stanford University Medical Center, CA

  • Pearl Quijada, PhD

    MR5 Room 3005
    CVRC Seminar Series

    TBD  Assistant Professor, Department of Integrative Biology and Physiology, University of California, Los Angeles

  • Robert Baur, PhD

    MR5 Room 3005
    CVRC Seminar Series

    TBD Florence Irving Assistant Professor of Medical Sciences, Cardiometabolic Genomics Program, Div. of Cardiology, Dept. of Medicine, Columbia University Irving Medical Center, New York, NY

  • Katie Pavelec, PhD

    MR5 Room 3005
    CVRC Seminar Series

    TBD Postdoctoral Research Fellow, Wolf Lab, University of Virginia, Charlottesville, VA